Start
Entdecken
nav.journalClub
Trends
Mehr
synapse
⌘+K
Sprache
Deutsch
Deutsch
From Signaling Pathways to Combination Therapy: Bioactive Compounds against Cancer Stem Cells | Synapse
March 3, 2026
From Signaling Pathways to Combination Therapy: Bioactive Compounds against Cancer Stem Cells
PC
P. S. V. V. Charan
NP
Nikitha S. Pai
NN
Nivruthi A. Naik
See all
Key Points
Combination therapy effectively targets cancer stem cells through synergistic bioactive compounds, showing promise in treatment.
The use of bioactive compounds in treatment strategies demonstrated enhanced effects in managing cancer stem cells over standard therapies.
Assessment focused on current knowledge of signaling pathways involved in cancer stem cells, offering insights for future research.
This approach highlights the potential for new treatment strategies, but further studies are necessary to validate effectiveness in clinical settings.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Charan et al. (Mon,) studied this question.
synapsesocial.com/papers/69a7658dbadf0bb9e87d9862
https://doi.org/https://doi.org/10.1007/s12015-026-11057-0